Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Assets (2016 - 2025)

Historic Return on Assets for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to 0.13%.

  • Corcept Therapeutics' Return on Assets fell 600.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.19% for FY2024, which is 200.0% up from last year.
  • Per Corcept Therapeutics' latest filing, its Return on Assets stood at 0.13% for Q3 2025, which was down 600.0% from 0.16% recorded in Q2 2025.
  • Corcept Therapeutics' Return on Assets' 5-year high stood at 0.25% during Q1 2022, with a 5-year trough of 0.13% in Q3 2025.
  • In the last 5 years, Corcept Therapeutics' Return on Assets had a median value of 0.18% in 2021 and averaged 0.18%.
  • As far as peak fluctuations go, Corcept Therapeutics' Return on Assets surged by 700bps in 2022, and later tumbled by -900bps in 2023.
  • Corcept Therapeutics' Return on Assets (Quarter) stood at 0.22% in 2021, then fell by -19bps to 0.18% in 2022, then fell by -4bps to 0.17% in 2023, then fell by 0bps to 0.17% in 2024, then decreased by -25bps to 0.13% in 2025.
  • Its Return on Assets stands at 0.13% for Q3 2025, versus 0.16% for Q2 2025 and 0.16% for Q1 2025.